Amgen Inc.

Roche Strikes $3.1 Billion Deal for Obesity Drugmaker

10:59 a.m. Dec. 4, 2023

- Adam Clark

Worried About a Weight-Loss Stock Bubble? Here Are Some Alternatives.

9:57 a.m. Dec. 1, 2023

- Jack Hough

Potential Cigna-Humana Deal Shows the Limits of Biden's Antitrust Push

4:19 p.m. Nov. 30, 2023

- Joe Light

Not much ‘low-hanging fruit’ left: Here’s the investing advice Charlie Munger offered in one of his last-ever interviews

4:24 a.m. Nov. 29, 2023

- Barbara Kollmeyer

New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade

8:01 a.m. Nov. 22, 2023

- Christine Idzelis

Heart Disease Breakthrough by Gene-Editor Verve Knocks Its Stock for a Loop

7:20 p.m. Nov. 13, 2023

- Bill Alpert

The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman — and Martin Shkreli 

9:00 a.m. Nov. 11, 2023

- Eleanor Laise

Dow's nearly 250-point fall led by losses in shares of Amgen, Home Depot

2:42 p.m. Nov. 9, 2023

- MarketWatch Automation

Amgen, Home Depot share losses contribute to Dow's 150-point drop

1:08 p.m. Nov. 9, 2023

- MarketWatch Automation

Amgen started at hold with $240 stock price target at Deutsche Bank

10:26 a.m. Nov. 9, 2023

- Tomi Kilgore

Pharma Stocks Are Bleeding. 2 Look Like Bargains.

10:51 a.m. Nov. 6, 2023

- Josh Nathan-Kazis

Dow up 200 points on gains in Amgen, Walgreens Boots shares

9:45 a.m. Nov. 2, 2023

- MarketWatch Automation

Amgen upgraded to buy from hold at Truist

8:51 a.m. Nov. 2, 2023

- Tomi Kilgore

Novo Nordisk Earnings Surge. It Can't Make Weight-Loss Drugs Fast Enough.

4:54 a.m. Nov. 2, 2023

- Josh Nathan-Kazis

GSK Raises Guidance on Strong Sales of Arexvy Vaccine

10:55 a.m. Nov. 1, 2023

- Josh Nathan-Kazis

Amgen gets FDA approval for its inflammatory diseases treatment Wezlana

7:22 p.m. Oct. 31, 2023

Dow records first 3-month losing streak since March 2020 as investors await Wednesday Fed decision

4:45 p.m. Oct. 31, 2023

- Frances Yue

Caterpillar, JetBlue, Sarepta, Catalent, Lattice, Pinterest, Wolfspeed, and More Stock Market Movers

4:14 p.m. Oct. 31, 2023

- Joe Woelfel

Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait

2:14 p.m. Oct. 31, 2023

- Ciara Linnane

Amgen Boosts Revenue Guidance

11:13 a.m. Oct. 31, 2023

- Emily Dattilo

Puerto Rico Was Supposed to Be John Paulson’s Paradise. Then Came the Lawsuits.

2:34 a.m. Nov. 17, 2023

- The Wall Street Journal Interactive Edition

Same Drug, Two Prices: Why the Higher Price Prevails

2:34 a.m. Nov. 9, 2023

- The Wall Street Journal Interactive Edition

Never Mind Covid, Investors Want a Pfizer Obesity Pill

1:33 a.m. Nov. 1, 2023

- The Wall Street Journal Interactive Edition

Amgen Could Get a Piece of the Obesity Market

1:33 a.m. Sept. 28, 2023

- The Wall Street Journal Interactive Edition

FTC Sues Amazon, Alleging Illegal Online-Marketplace Monopoly

7:28 a.m. Sept. 28, 2023

- The Wall Street Journal Interactive Edition

The Hedge Fund That Made a Killing Betting Against Lina Khan

5:05 a.m. Sept. 25, 2023

- The Wall Street Journal Interactive Edition

A New Way to Protect Against Heart Attacks

1:02 p.m. Sept. 25, 2023

- The Wall Street Journal Interactive Edition

Big Pharma’s Battle With the Biden Administration Could Have Legs

8:46 a.m. Sept. 13, 2023

- The Wall Street Journal Interactive Edition

Biden FTC’s Antitrust Bark Proves Worse Than Its Bite

1:33 a.m. Sept. 7, 2023

- The Wall Street Journal Interactive Edition

Amgen’s Deal for Horizon Therapeutics Clears Key Hurdle

1:32 a.m. Sept. 2, 2023

- The Wall Street Journal Interactive Edition

Drug Price Controls Mean Slower Cures

3:44 p.m. Aug. 30, 2023

- The Wall Street Journal Interactive Edition

Expensive Drugs Targeted for First U.S. Price Negotiations

2:40 p.m. Oct. 10, 2023

- The Wall Street Journal Interactive Edition

FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics

5:03 p.m. Aug. 28, 2023

- The Wall Street Journal Interactive Edition

Biotech M&A Rebound Bodes Well for Venture Investors

1:33 a.m. Aug. 11, 2023

- The Wall Street Journal Interactive Edition

Apple, Amazon, Starbucks to Report in Packed Earnings Week

12:43 p.m. Aug. 1, 2023

- The Wall Street Journal Interactive Edition

How AbbVie’s Humira Still Reigns, Despite New Competition

8:55 a.m. Aug. 1, 2023

- The Wall Street Journal Interactive Edition

A Soap Maker Cracks the Code to ‘Made in America’

1:34 a.m. July 26, 2023

- The Wall Street Journal Interactive Edition

Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion

3:15 p.m. July 14, 2023

- The Wall Street Journal Interactive Edition

Lina Khan Is Taking on the World’s Biggest Tech Companies—and Losing

6:00 a.m. July 13, 2023

- The Wall Street Journal Interactive Edition

The Drugs That Are Gaining on Ozempic

5:30 p.m. July 3, 2023

- The Wall Street Journal Interactive Edition